Nanosonics Limited Stock
Stocks
NAN
AU000000NAN9
Advanced Medical Equipment & Technology
OTC Markets Traded|
Market Closed -
Australian S.E.
13:10:12 12/11/2026 HKT
|
5-day change | 1st Jan Change | ||
| 2.830 AUD | +1.80% |
|
-4.07% | -28.72% |
| 11-11 | Nanosonics Secures Second US FDA 510(k) Clearance for Coris System | MT |
| 11-04 | Nanosonics Limited - Shareholder/Analyst Call |
| Market Cap | 831M 569M 513M 474M 429M 811M 53.41B 5.68B 2.26B 28.6B 2.14B 2.09B 91.02B | P/E 2027 * |
72.4x | P/E 2028 * | 47.6x |
|---|---|---|---|---|---|
| Enterprise Value | 713M 489M 440M 407M 368M 696M 45.82B 4.88B 1.94B 24.54B 1.83B 1.79B 78.09B | EV / Sales 2027 * |
3.25x | EV / Sales 2028 * | 2.98x |
| Free-Float |
91.62% | Yield 2027 * |
-
| Yield 2028 * | - |
| Markets | Quality | ||
|---|---|---|---|
Australian S.E.
| NAN | Delayed | |
OTC Markets
| NNCSF | Delayed | |
|
Deutsche Boerse AG
| OQS | Delayed | |
|
Börse Stuttgart
| OQS | Delayed | |
|
Berne S.E.
| OQS | End-of-day quote |
Last Transcript: Nanosonics Limited
| 1 day | +1.80% | ||
| 1 week | -4.07% | ||
| Current month | -6.60% | ||
| 1 month | -0.70% | ||
| 3 months | -20.06% | ||
| 6 months | -13.19% | ||
| Current year | -28.72% |
| 1 week | 2.78 |  | 2.95 |
| 1 month | 2.74 | | 3.14 |
| Current year | 2.64 | | 4.23 |
| 1 year | 2.64 | | 4.4 |
| 3 years | 2.59 | | 5.18 |
| 5 years | 2.59 | | 6.51 |
| 10 years | 2.15 | | 8.25 |
| Manager | Title | Age | Since |
|---|---|---|---|
Michael Kavanagh
CEO | Chief Executive Officer | - | 21/10/2013 |
Jason Burriss
DFI | Director of Finance/CFO | - | 03/10/2023 |
Derek Minihane
CTO | Chief Tech/Sci/R&D Officer | - | 01/09/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Michael Kavanagh
BRD | Director/Board Member | - | 30/07/2012 |
Steven Sargent
CHM | Chairman | 64 | 01/07/2022 |
Marie McDonald
BRD | Director/Board Member | 70 | 24/10/2016 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 22/9/26 | Exercice | Chief Executive Officer | -21,914 | 0.0073% | ||
| 22/9/26 | Exercice | Chief Executive Officer | 21,914 | 0.0073% | ||
| 10/9/26 | Buy | Director | 18,500 | 0.0062% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.80% | -4.07% | -32.62% | -31.31% | 569M | |
| -0.07% | +1.64% | +22.37% | +60.05% | 266B | |
| -0.34% | +0.16% | +9.05% | +19.45% | 166B | |
| -0.11% | -6.76% | -21.43% | +62.00% | 156B | |
| +0.96% | -1.51% | -55.97% | -12.47% | 65.41B | |
| +1.73% | +6.48% | +24.25% | +64.79% | 60.84B | |
| +1.63% | -2.97% | -2.05% | -8.59% | 53.75B | |
| -0.52% | -0.12% | +18.42% | +63.13% | 49.89B | |
| -0.26% | -1.89% | +1.90% | +84.62% | 49.34B | |
| -0.97% | +0.71% | +21.95% | +84.00% | 46.28B | |
| Average | +0.37% | -0.63% | -1.41% | +38.57% | 91B | |
| Weighted average by Cap. | +0.06% | -0.39% | +4.18% | +46.76% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 219M 150M 135M 125M 113M 214M 14.08B 1.5B 597M 7.54B 563M 551M 24B | 239M 164M 148M 136M 123M 233M 15.36B 1.63B 651M 8.23B 615M 602M 26.18B |
| Net income | 10.37M 7.1M 6.4M 5.92M 5.35M 10.12M 666M 70.89M 28.26M 357M 26.66M 26.09M 1.14B | 16.42M 11.25M 10.14M 9.37M 8.47M 16.02M 1.06B 112M 44.75M 565M 42.22M 41.32M 1.8B |
| Net Debt | -118M -80.9M -72.91M -67.36M -60.9M -115M -7.59B -807M -322M -4.06B -304M -297M -12.93B | -119M -81.33M -73.3M -67.72M -61.22M -116M -7.63B -812M -323M -4.09B -305M -299M -13B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 12/11/26 | A$2.830 | +1.80% | 1,034,752 |
| 11/11/26 | A$2.780 | -2.46% | 512,395 |
| 10/11/26 | A$2.850 | -1.38% | 715,361 |
| 09/11/26 | A$2.890 | 0.00% | 845,395 |
| 06/11/26 | A$2.890 | -2.03% | 713,787 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- NAN Stock
Select your edition
All financial news and data tailored to specific country editions
